
bit.biorevenue
Cambridge, England, United KingdomFounded 2019
bit.bio is an award-winning human synthetic biology company focused on coding cells for novel cures. They have developed an end-to-end platform for producing human cells for research, drug discovery, and cell therapy.
bit.bio revenue
bit.bio has not published its revenue. GetLatka estimates it at about $13.9M a year (December 2025).
| As of | Revenue | Source |
|---|---|---|
| Dec 2025 | $13.9MEST | GetLatka estimate |
bit.bio founders & employees
Mark Kotter founded bit.bio in 2019. bit.bio has 100 employees (December 2025, LinkedIn).
- Mark KotterFounder & Board Member
bit.bio FAQ
What is bit.bio's revenue?
GetLatka estimates bit.bio's revenue at about $13.9M a year (December 2025). The company hasn't published its own figure.
How many employees does bit.bio have?
bit.bio has 100 employees as of December 2025, according to LinkedIn.
Who founded bit.bio?
Mark Kotter founded bit.bio in 2019.
Categories
Companies in
How this page is sourced
1 from public sources · 1 estimate. Founder figures link to the second they were said; public figures name their source; estimates are marked EST and say whose they are. Not financial advice.
Updated Oct 13, 2026Data disclaimerReport a correctionClaim this profileRun bit.bio? Join the podcast